Yutian L. Zou

651 East Dongfeng Road
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 85 publications

Targeting the neuro-immune crosstalk in breast cancer brain metastases.

Targeting the neuro-immune crosstalk in breast cancer brain metastases.

Journal: Journal for immunotherapy of cancer

Published: March 13, 2026

Antibody-drug conjugates in breast cancer brain and leptomeningeal metastases: mechanistic insights and therapeutic progress.

Antibody-drug conjugates in breast cancer brain and leptomeningeal metastases: mechanistic insights and therapeutic progress.

Journal: Cancer metastasis reviews

Published: February 26, 2026

ADSL drives fumarate mediated scrib-rictor complex formation to promote metastasis dissemination in triple-negative breast cancer.

ADSL drives fumarate mediated scrib-rictor complex formation to promote metastasis dissemination in triple-negative breast cancer.

Journal: Molecular cancer

Published: January 17, 2026

Co-targeting ferroptosis and immune evasion through small molecules in breast cancer.

Co-targeting ferroptosis and immune evasion through small molecules in breast cancer.

Journal: Journal of translational internal medicine

Published: December 24, 2025

ZBED6-driven nucleotide metabolic reprogramming improves sensitivity to anti-PD1 therapy in NK/T cell lymphoma.

ZBED6-driven nucleotide metabolic reprogramming improves sensitivity to anti-PD1 therapy in NK/T cell lymphoma.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: December 23, 2025

Traditional Chinese medicine and formulations for the treatment of colorectal cancer: Preclinical studies based on the concept of strengthening the body and eliminating pathogens.

Traditional Chinese medicine and formulations for the treatment of colorectal cancer: Preclinical studies based on the concept of strengthening the body and eliminating pathogens.

Journal: Cancer letters

Published: November 28, 2025

IRG1/itaconate/NRF2/GSH axis in tumor-associated macrophages drives therapy resistance and immune evasion in BRCA1-deficient breast cancer.

IRG1/itaconate/NRF2/GSH axis in tumor-associated macrophages drives therapy resistance and immune evasion in BRCA1-deficient breast cancer.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Disulfidptosis in cancer: from redox stress to therapeutic strategy.

Disulfidptosis in cancer: from redox stress to therapeutic strategy.

Journal: Cancer gene therapy

Published: September 28, 2025

Copper orchestrates triple-negative breast cancer progression via the STEAP3-dependent CDK16-JAK1 activation.

Copper orchestrates triple-negative breast cancer progression via the STEAP3-dependent CDK16-JAK1 activation.

Journal: Cancer letters

Published: September 17, 2025

Hijacking the bone niche: mechanistic insights into bone metastasis in breast cancer.

Hijacking the bone niche: mechanistic insights into bone metastasis in breast cancer.

Journal: Bone research

Published: August 25, 2025

Loss of the tumor suppressor PTEN activates cell-intrinsic interferon signaling to drive immune resistance.

Loss of the tumor suppressor PTEN activates cell-intrinsic interferon signaling to drive immune resistance.

Journal: Genes & development

Published: August 20, 2025

PRMT1-Mediated PARP1 Methylation Drives Lung Metastasis and Chemoresistance via P65 Activation in Triple-Negative Breast Cancer.

PRMT1-Mediated PARP1 Methylation Drives Lung Metastasis and Chemoresistance via P65 Activation in Triple-Negative Breast Cancer.

Journal: Research (Washington, D.C.)

Published: May 15, 2025

Showing 1-12 of 85

Last Updated: 09/26/2026